This is to inform you that the Company has closed the trading window for the earnings of the Quarter and Year ending March 31, 2024 in compliance with the SEBI (Prohibition of Insider Trading) ...
WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...
The company also notes that specialty generic products accounted for less than 1.5% of its clients’ total drug spending between 2017 and 2022. “Also, the FTC buries in footnote 39 its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback